These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 17623113)

  • 1. Efficacy of open flap debridement with and without enamel matrix derivatives in the treatment of mandibular degree II furcation involvement.
    Chitsazi MT; Mostofi Zadeh Farahani R; Pourabbas M; Bahaeddin N
    Clin Oral Investig; 2007 Dec; 11(4):385-9. PubMed ID: 17623113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effectiveness of enamel matrix derivative, bone grafts, and membrane in the treatment of mandibular Class II furcation defects.
    Jaiswal R; Deo V
    Int J Periodontics Restorative Dent; 2013; 33(2):e58-64. PubMed ID: 23484181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyapatite/β-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial.
    Peres MF; Ribeiro ED; Casarin RC; Ruiz KG; Junior FH; Sallum EA; Casati MZ
    J Clin Periodontol; 2013 Mar; 40(3):252-9. PubMed ID: 23379539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of anatomic features on the effectiveness of enamel matrix derivative proteins in the treatment of proximal Class II furcation involvements.
    Casarin RC; Ribeiro Edel P; Ribeiro FV; Nociti FH; Sallum AW; Sallum EA; Casati MZ
    Quintessence Int; 2009 Oct; 40(9):753-61. PubMed ID: 19862402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and radiographic evaluation of guided tissue regeneration in the treatment of class II furcation defects. A randomized clinical trial.
    Cury PR; Jeffcoat MK; Sallum AW; Cafesse R; Nociti Júnior FH; Sallum EA
    Am J Dent; 2003 Sep; 16 Spec No():13A-16A. PubMed ID: 14674492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part II: secondary outcomes.
    Meyle J; Gonzales JR; Bödeker RH; Hoffmann T; Richter S; Heinz B; Arjomand M; Reich E; Sculean A; Jepsen K; Jepsen S
    J Periodontol; 2004 Sep; 75(9):1188-95. PubMed ID: 15515332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combined regenerative treatments in human mandibular class II furcation defects.
    Santana RB; de Mattos CM; Van Dyke T
    J Periodontol; 2009 Nov; 80(11):1756-64. PubMed ID: 19905945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enamel matrix protein derivative plus synthetic bone substitute for the treatment of mandibular Class II furcation defects: a case series.
    Queiroz LA; Santamaria M; Casati M; Silverio K; Nociti-Junior F; Sallum E
    Quintessence Int; 2015 Mar; 46(3):199-205. PubMed ID: 25386635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing treatment outcomes in mandibular Class II furcation defects.
    Tsao YP; Neiva R; Al-Shammari K; Oh TJ; Wang HL
    J Periodontol; 2006 Apr; 77(4):641-6. PubMed ID: 16584345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of mandibular degree II furcation defects: a randomized controlled clinical trial.
    Bajaj P; Pradeep AR; Agarwal E; Rao NS; Naik SB; Priyanka N; Kalra N
    J Periodontal Res; 2013 Oct; 48(5):573-81. PubMed ID: 23317096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
    Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
    J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of endodontic treatment in the post-surgical healing of human Class II furcation defects.
    de Miranda JL; Santana CM; Santana RB
    J Periodontol; 2013 Jan; 84(1):51-7. PubMed ID: 22769438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of anorganic bovine bone xenograft with a bioabsorbable collagen barrier in the treatment of molar furcation defects.
    Houser BE; Mellonig JT; Brunsvold MA; Cochran DL; Meffert RM; Alder ME
    Int J Periodontics Restorative Dent; 2001 Apr; 21(2):161-9. PubMed ID: 11829390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the outcome of regenerative therapy in mandibular Class II furcations: Part I.
    Bowers GM; Schallhorn RG; McClain PK; Morrison GM; Morgan R; Reynolds MA
    J Periodontol; 2003 Sep; 74(9):1255-68. PubMed ID: 14584858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided tissue regeneration in human Class II furcation defects using a diphenylphosphorylazide-cross-linked collagen membrane: a consecutive case series.
    Zahedi CS; Miremadi SA; Brunel G; Rompen E; Bernard JP; Benque E
    J Periodontol; 2003 Jul; 74(7):1071-9. PubMed ID: 12931772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.